Detalles de la búsqueda
1.
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
Diabetes Obes Metab
; 25(11): 3212-3222, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37551542
2.
Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
J Diabetes Sci Technol
; : 19322968231161320, 2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36949671
3.
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
BMJ Open
; 12(2): e050635, 2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110310
4.
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Lancet Diabetes Endocrinol
; 10(10): 720-731, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36058207
5.
Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
Diabetes Technol Ther
; 20(11): 758-766, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30325656
6.
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management.
Diabetes Technol Ther
; 18(5): 288-91, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26907513
Resultados
1 -
6
de 6
1
Próxima >
>>